These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11964488)

  • 1. Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse.
    Holder HD
    J Ment Health Policy Econ; 1998 Mar; 1(1):23-29. PubMed ID: 11964488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis.
    Parthasarathy S; Weisner C; Hu TW; Moore C
    J Stud Alcohol; 2001 Jan; 62(1):89-97. PubMed ID: 11271969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental health and substance abuse parity: a case study of Ohio's state employee program.
    Sturm R; Goldman W; McCulloch J
    J Ment Health Policy Econ; 1998 Oct; 1(3):129-134. PubMed ID: 11971152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and usage impacts of treatment initiation: a comparison of alcoholism and drug abuse treatments.
    Goodman AC; Nishiura E; Humphreys RS
    Alcohol Clin Exp Res; 1997 Aug; 21(5):931-8. PubMed ID: 9267547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Determinants of Multiple Treatment Episodes for Substance Abusers.
    Goodman AC; Hankin JR; Kalist DE; Peng Y; Spurr SJ
    J Ment Health Policy Econ; 2001 Jun; 4(2):65-77. PubMed ID: 11967467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit analysis of drug treatment services: review of the literature*.
    Cartwright WS
    J Ment Health Policy Econ; 2000 Mar; 3(1):11-26. PubMed ID: 11967433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and cost impact of integrating substance abuse treatment and primary care.
    Parthasarathy S; Mertens J; Moore C; Weisner C
    Med Care; 2003 Mar; 41(3):357-67. PubMed ID: 12618639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcoholism treatment and potential health care cost saving.
    Holder HD
    Med Care; 1987 Jan; 25(1):52-71. PubMed ID: 3100880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of alcoholism treatment on total health care costs: a six-year study.
    Holder HD; Hallan JB
    Adv Alcohol Subst Abuse; 1986; 6(1):1-15. PubMed ID: 3101439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs, benefits, and net benefit of 13 inpatient substance use treatments for 14,947 women and men.
    Hornack SE; Yates BT
    Eval Program Plann; 2023 Apr; 97():102198. PubMed ID: 36702008
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.